Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
Ocugen Shares Fall, Despite Positive Eye Disorder Trial
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
Johnson & Johnson Brushes Off MFN Impact, Sees Strong Growth for 2026
Top 10 Most Popular Drug Hunter Reviews of 2025
JPM26: Filling C-Suites, Union Square—And Elevators—With Pink
Gepotidacin
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
Medtronic Completes First Hugo Case in the US
Proteasomes: A Novel Approach to Target the Immune System
CMS's Medicare Price Negotiations Start Round Three
Opinion: Pricing Transparency Is Coming to the Pharma Industry
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
J&J Reports Positive Phase 3 Data for Tecvayli in Earlier Blood Cancer Setting
ImmunityBio Rises as Route Opens to Broader Anktiva Label
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
J&J Bets on Isomorphic for AI-Powered Drug Hunt
Charlotte Emerging as a Global Leader in Health Care Innovation and Med Tech
11 Companies Hiring Manufacturing Professionals Now
J&J Strikes Drug Pricing, Tariff Deal with the White House
The New Gold Rush in Brain Science
Johnson & Johnson’s Hematology Portfolio: Breakthroughs to Watch
J&J Builds Case for Earlier Tecvayli Use in Multiple Myeloma
Boehringer Signs €1bn+ Deal for Simcere IBD Candidate
2025 Novel Large Molecule FDA Drug Approvals
Fenebrutinib (GDC-0853)
Johnson & Johnson’s Pipeline Strategy: What Does 2026 Have in Store for the Big Pharma?
Proxima Raises $80M in Seed Funding
Alumis Soars as TYK2 Drug Hits Mark in Psoriasis Trials
STAT+: Novo Strikes Deal for Diabetes Cell Therapies
AbbVie Turbocharges Its US Investment Promise to $100bn
Biogen’s Much Anticipated Tau Readout in Alzheimer’s Will Spur More Questions
Censia AI Adds Peter Fasolo to Boost Workforce Intelligence
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
FDA Lays Out New Path to Speed Development of Multiple Myeloma Drugs
M&A Trends: Outlook for Healthcare, Tech, Banking, & More
JNJ-8003
Pharma Bets Big on AI Platforms with Flurry of New Year Deals
J&J Jumps on the MFN Pricing Train
Bone Disease Readout Sinks Mereo, Ultragenyx Shares: Clinical Roundup
Halozyme Diversifies in Drug Delivery with Surf Bio Buy
J&J Praises New FDA Guidance to Speed Development of Multiple Myeloma Drugs
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence
Gedatolisib
J&J, Isomorphic Sign Research Deal for AI-Made Molecules
HHS Is Making an AI Tool to Create Hypotheses About Vaccine Injury Claims
J&J Eyes $100B in Sales Amid Gains for Cancer, Immune Drugs